Denali Therapeutics Inc. Noncash or Part Noncash Acquisition, Intangible Assets Acquired
Denali Therapeutics Inc. (DNLI) reported Noncash or Part Noncash Acquisition, Intangible Assets Acquired of $7.20 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1 · last filed 2026-08-06
- Denali Therapeutics Inc. noncash or part noncash acquisition, intangible assets acquired for the quarter ending 2026-06-30 was -$28.80M.
- Denali Therapeutics Inc. noncash or part noncash acquisition, intangible assets acquired for the quarter ending 2026-03-31 was $36.00M.
- Denali Therapeutics Inc. noncash or part noncash acquisition, intangible assets acquired for the quarter ending 2025-06-30 was $0.00.
- Denali Therapeutics Inc. noncash or part noncash acquisition, intangible assets acquired for the quarter ending 2025-03-31 was $0.00.
| Period end | Noncash or Part Noncash Acquisition, Intangible Assets Acquired 3 month | Noncash or Part Noncash Acquisition, Intangible Assets Acquired 6 month |
|---|---|---|
| 2026-06-30 | -$28.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $7.20M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $36.00M 10-Q · filed 2026-05-07 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $0.00 10-Q · filed 2026-08-06 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |